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ABSTRACT: An isothiourea-catalyzed enantioselective annulation protocol using indolin-2-imines with a series of α,β-unsaturated 
p-nitrophenyl esters for the synthesis of tetrahydro-α‑carbolinones has been developed. Using 5 mol% of the isothiourea HyperBTM 
as the Lewis base catalyst, this process allows the enantioselective preparation of a range of C(4)-substituted tetrahydro-α‑carboli-
nones in good to excellent yield and with high enantioselectivity (20 examples, 32-99% yield and up to 99:1 er).  
Nitrogen-containing heterocycles are important structural mo-
tifs prevalent in a diverse range of natural products and medic-
inal agents. Their importance is readily quantified as 59% of US 
FDA approved small-molecule drugs contain a nitrogen heter-
ocycle,1 with these heterocycles commonly incorporated into 
molecules to improve physicochemical properties.2 α‑Car-
bolines and their tetrahydro-α‑carbolinone derivatives (Figure 
1A) are a representative class of N-heterocycle that are fre-
quently found in natural compounds with diverse biological ac-
tivities.3 Although a range of methods for the construction of β- 
and γ-carbolinone skeletons has been reported,4 limited syn-
thetic routes to α‑carbolinones have been developed, with enan-
tioselective methods rare. For example, Zhou and co-workers 
have developed a sequential Michael addition/amidation/reduc-
tive cyclization process using oxindole nucleophiles with Mi-
chael acceptors to give tetrahydro-α‑carbolinones in racemic 
form.5,6 Alternatively, Li and co-workers have demonstrated the 
enantioselective synthesis of tetrahydro-α‑carbolinones through 
an NHC-catalyzed formal [4+2] cyclization of aza-dienes with 
an azolium enolate derived from -chloroaldehydes.7 Recently, 
Ye and co-workers reported an elegant oxidative NHC-
catalyzed annulation of indolin-2-imines with in situ generation 
,-unsaturated acyl azolium intermediates for the preparation 
of racemic tetrahydro-α-carbolinones bearing C(4)-aryl and 
C(4)-alkyl groups (Figure 1B) that served as precedent for this 
work.8  
Isothioureas are versatile and powerful Lewis base catalysts of 
broad synthetic utility,9 and have been utilized for the in situ 
generation of chiral α,β-unsaturated acyl ammonium species for 
use in a range of reaction processes.10 In previous work, we and 
others have harnessed this intermediate in Michael addition and 
subsequent lactonization or lactamization processes to generate 
carbo- and heterocycles.10a,f,l,m Building upon these precedents, 
this manuscript showcases the use of isothioureas for the enan-
tioselective synthesis of tetrahydro-α-carbolinones using in-
dolin-2-imines and ,-unsaturated esters as starting materials 
(Figure 1C). 
Figure 1. Synthesis of Tetrahydro-α-carbolinones 
























Initial investigations studied the proposed annulation between 
indolin-2-imine 2 and β-trifluoromethyl α,β-unsaturated p-ni-
trophenyl (PNP) ester 1 using (2S,3R)-HyperBTM 3 (20 mol %) 
and an equivalent of iPr2NEt in THF at room temperature. The 
desired C(4)-trifluoromethyl substituted tetrahydro-α-carboli-
none product 6 was afforded in 53% yield with 98:2 er (Table 
1, entry 1). Use of alternative isothiourea catalysts (R)-BTM 4 
and (S)-tetramisole hydrochloride 5 gave lower product conver-
sion and yield, despite promising enantioselectivity with BTM 
(entries 2–3). Further optimisation varied both base and solvent 
(entries 4–10). Variation of base showed that NaHCO3 gave im-
proved yield and excellent er in THF. A screen of solvents 
showed that an excellent 91% isolated yield of 6 with 97:3 er 
was observed in acetonitrile (entry 10). Carrying out the reac-
tion without additional base provided a lower isolated yield 
(65%, entry 11). Decreasing the catalyst loading to 5 mol% 
gave 6 in still excellent yield and enantioselectivity (entry 12). 
Finally, improved yield while maintaining high enantioselectiv-
ity was observed (up to 99% yield and 97:3 er) when using a 
small excess (1.2 equiv) of imine 2 at room temperature or at 
0 °C (entries 13–14).  
Table 1. Optimization of Reaction Conditionsa 
  





1 3 iPr2NEt THF 53 98:2 
2 4 iPr2NEt THF 37 98:2 
3 5 iPr2NEt THF 6 15:85 
4 3 Et3N THF 40 98:2 
5 3 Na2CO3 THF 12 >99:1 
6 3 NaHCO3 THF 68 >99:1 
7 3 NaHCO3 toluene 81 98:2 
8 3 NaHCO3 CH2Cl2 80 98:2 
9 3 NaHCO3 dioxane 80 83:17 
10 3 NaHCO3 CH3CN 91 97:3 
11 3 - CH3CN 65 97:3 
12d 3 NaHCO3 CH3CN 83 96:4 
13d,e 3 NaHCO3 CH3CN 99 97:3 
14 d,f 3 NaHCO3 CH3CN 99 97:3 
a Unless indicated otherwise, reactions were carried out in 1 mL of sol-
vent using 0.1 mmol of 1, 0.1 mmol of 2, 0.1 mmol base in the presence 
of 20 mol% of catalysts 3–5 at rt. b Isolated yield given. c Determined by 
HPLC analysis on a chiral stationary phase and given as a ratio of 
(S):(R). d 5 mol% of 3 used. e 0.12 mmol of 2 used.  f Carried out at 0 °C.  
Using the optimal reaction conditions, variation of the C(3)-
substituent within the α,β-unsaturated PNP ester to construct 
C(4)-substituted tetrahydro-α-carbolinones was explored 
(Scheme 1). C(3)-Chlorodifluoromethyl-, -bromodifluorome-
thyl-, -difluoromethyl-, and -perfluoroethyl-substituted esters 
gave the corresponding products 18–21 in good to excellent 
yields and with high enantioselectivity. Notably,10g challenging 
C(3)-aliphatic substituents that are typically recalcitrant when 
using α,β-unsaturated PNP esters are also tolerated, giving the 
desired products 22–24 in moderate yield (38–59%) but with 
excellent enantioselectivity. While the corresponding C(3)-phe-
nyl-substituted ester provided 25 in 53% yield but poor 57:43 
er, the use of the corresponding isopropyl carbonic anhydride 
using iPr2NEt as base in THF gave 25 in 40% yield and im-
proved 88:12 er. Other C(3)-substituted esters containing C(3)-
ester and C(3)-amide functional groups gave the corresponding 
products 26–27 in good yield and good to excellent enantiose-
lectivity.  
Scheme 1. Variation of the α,β-Unsaturated Aryl Estera 
 
a Isolated yield given; er determined by HPLC analysis on a chiral stationary 
phase. b Carried out in THF using (E)-cinnamic (isopropyl carbonic) anhy-
dride 17 and iPr2NEt. 
Further work probed the scope of this transformation through 
structural variation of the N-substituent and aryl substitution 
pattern within the indolin-2-imine component (Scheme 2). N-
Benzyl substitution led to decreased yield over the N-Me vari-
ant, giving 37 in 32% yield but excellent 96:4 er. Aryl substitu-
ent variation proved more tolerant to steric and electronic vari-












































HyperBTM 3 (5 mol% )
NaHCO3 (1 equiv)


































18, 93%, 97:3 er 19, 95%, 94:6 er
21, 97%, 99:1 er



















23, 38%, 93:7 er 24, 38%, 96:4 er 25,b 40%, 88:12 er













6, 99%, 97:3 er

















tron-withdrawing halogen or electron-donating methyl substit-
uents tolerated. Notably, the substitution pattern has an interest-
ing influence on the observed reactivity. 6-Substituted indolin-
2-imines gave the products 38–39, 42 and 44 in good 72–76% 
yield with 95:5–99:1 er. In contrast, incorporation of substitu-
ents into the 4-, 5- or 7-position of the indolin-2-imine substrate 
led to the corresponding products 40, 41, 43 and 45 in moderate 
37–54% yield but with good enantioselectivity (up to 98:2 er). 
Scheme 2. Variation of Indolin-2-imine componenta 
 
 a Isolated yield given; er was determined by HPLC analysis on a chiral sta-
tionary phase. 
The scalability of this process was demonstrated by performing 
the reaction of indolin-2-imine 2 with β-trifluoromethyl α,β-un-
saturated PNP ester 1 on a gram scale, giving 6 in excellent 87% 
yield and 97:3 er (Scheme 3A). To further demonstrate the util-
ity of the -carbolinone products, 6 was derivatized to a range 
of compounds (Scheme 3B). Treatment of 6 with Mg/methanol 
gave ring-opened product 46 in 99% yield and 97:3 er.8 Oxida-
tion of 6 with m-CPBA gave the corresponding epoxide in situ, 
with subsequent rearrangement yielding spirolactone 47 as a 
single diastereoisomer in moderate isolated yield but high er. 
The absolute configuration of 47 was determined by single crys-
tal X-ray diffraction, which also served to assign the absolute 
configuration at C(4) within 6, with all other -carbolinone 
products assigned by analogy.11 Alternatively, sequential reduc-
tion with LiAlH4 and triethylsilane gave tetrahydropryra-
noindole 48 in 68% yield and 97:3 er,7 while dehydrogenation 






Scheme 3. Gram-Scale Experiment and Derivatizations 
 
Based upon our previous mechanistic investigations in this area 
a simple catalytic cycle is proposed (Figure 2).10a Catalysis is 
initiated through rapid and reversible acylation of HyperBTM 3 
by the α,β-unsaturated ester 1 to give α,β-unsaturated acyl 
isothiouronium ion pair 50. The addition of enamine anion 51, 
generated from indoline-2-imine 2, to the α,β-unsaturated acyl 
isothiouronium 50 gives isothiouronium enolate 52. Subsequent 
proton transfer gives zwitterion 53. Finally, lactamization 
yields the product 6 and regenerates the isothiourea HyperBTM 
3. The stereochemical outcome of the reaction can be 
rationalised by the α,β-unsaturated acyl isothiouronium 50 
adopting an s-cis conformation, with a 1,5-S···O interaction 
between the acyl O and catalyst S providing a conformational 
lock.12 Enantioselective conjugate addition of the enamine 
anion to the α,β-unsaturated acyl isothiouronium 50 takes place 
anti- to the stereodirecting pseudo-axial phenyl substituent of 
the acylated HyperBTM isothiourea catalyst and determines the 
configurarion at C(4)-within the products.  
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In conclusion, an isothiourea-catalyzed enantioselective annu-
lation protocol of indolin-2-imines with a series of α,β-unsatu-
rated p-nitrophenyl esters for the synthesis of tetrahydro-α‑car-
bolinones has been developed. Using 5 mol% of isothiourea 
HyperBTM 3, this protocol allows the enantioselective prepa-
ration of a range of C(4)-substituted tetrahydro-α‑carbolinones 
in moderate to excellent yield and with excellent enantioselec-
tivity (20 examples, 32-99% yield and up to 99:1 er). The scope 
of the process has been demonstrated through variation in both 
C(3)-substitution within the α,β-unsaturated p-nitrophenyl es-
ter, as well as the N-substituent and aryl substitution pattern 
within the indolin-2-imine component. Further investigations 
from within our laboratory are concerned with alternative ap-
plications of isothioureas and harnessing the utility of ,-un-
saturated acyl ammonium intermediates.13 
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